SMTL ID : 6x8g.1

Crystal structure of TYK2 with Compound 22

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.21 Å

Oligo State

monomer

Ligands

1 x UWM: trans-3-(cyanomethyl)-3-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl}cyclobutane-1-carbonitrile(Non-covalent)

UWM.1: 21 residues within 4Å: Chain A: L.39, G.40, E.41, G.42, G.45, K.46, V.47, A.64, K.66, I.96, E.115, Y.116, V.117, P.118, L.119, G.120, R.163, N.164, L.166, G.176, D.177 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.39, A:V.47, A:V.47, A:L.166 Hydrogen bonds: A:G.42, A:V.117 Water bridges: A:R.37, A:K.66

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gerstenberger, B.S. et al., Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases. J.Med.Chem. (2020)

Release Date

2020-11-25

Peptides

Non-receptor tyrosine-protein kinase TYK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Non-receptor tyrosine-protein kinase TYK2

Related Entries With Identical Sequence